Adicet Bio Reports on Shareholder Vote
Ticker: ACET · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Adicet Bio held a shareholder vote on June 11th, details to follow.
AI Summary
Adicet Bio, Inc. filed an 8-K on June 13, 2025, reporting on a matter submitted to a vote of security holders on June 11, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
Shareholder votes can impact corporate governance, strategic decisions, and executive compensation, potentially affecting stock value.
Risk Assessment
Risk Level: low — This filing is procedural and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Adicet Bio, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- June 13, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- resTORbio, Inc. (company) — Former company name
FAQ
What specific matter was submitted to a vote of Adicet Bio's security holders on June 11, 2025?
The filing does not specify the exact matter voted upon, only that a submission to a vote of security holders occurred on June 11, 2025.
What was the outcome of the shareholder vote on June 11, 2025?
The filing does not disclose the results or outcome of the shareholder vote.
When did Adicet Bio file this 8-K report?
Adicet Bio filed this 8-K report on June 13, 2025.
What is Adicet Bio's principal executive office address?
Adicet Bio's principal executive offices are located at 131 Dartmouth Street, Floor 3, Boston, Massachusetts 02116.
Has Adicet Bio changed its name recently?
The filing indicates that Adicet Bio was formerly known as resTORbio, Inc., with a date of name change on October 24, 2017.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Adicet Bio, Inc. (ACET).